Recently the Australian Federal Government announced in the budget significant funding towards mental health initiatives, including $288.9m to approve an MBS item for the highly effective antidepressant treatment repetitive Transcranial Magnetic Stimulation (rTMS).
German-based leader of Transcranial Magnetic Stimulation devices, MAG & More, joins forces with neurocare group, a strong partnership which will enhance innovation and growth of neurocare's digital therapeutics platform.
Weiterlesen … neurocare and MAG & More join forces
As another key step towards its planned public listing, neurocare is very pleased to announce the closing of a significant financing round with its existing anchor investor bm-t and new strategic investor re.Mind.
Weiterlesen … neurocare announces financing round with bm-t and strategic investor Apeiron / re.Mind
neurocare AG announces change of legal form, its new Supervisory and Executive board and appoints Dr. Thomas Rudolf to the Executive Board
Weiterlesen … neurocare group AG takes next step towards IPO
October 10 is World Mental Health Day, 2020. We highlight the progress made in mental health therapeutics through the COVID-19 pandemic.
Weiterlesen … World Mental Health Day 2020
Interview with neuroCare Founder & Executive Chairman Thomas Mechtersheimer
Weiterlesen … neuroCare Group targeting ASX or NASDAQ First North IPO in 18 months
The investment will not only finance the company´s further expansion, including its Japan market entry, but also will safeguard neuroCare’s growth and planned IPO beyond the current COVID-19 crisis.
Weiterlesen … neuroCare Group receives 2nd investment from bm|t to fund further expansion
Visit our virtual stand at OHBM 2020. We look forward to meeting you there - virtually but still in personal contact.
Weiterlesen … Visit our virtual booth at OHBM 2020
neuroCare Group Founder & Executive Chairman, Thomas Mechtersheimer explains the fundamental role of sleep for people in high performance roles
Weiterlesen … Entrepreneurs need to understand Sleep, Resilience and High Performance
neuroCare Australia's Dr Trevor Brown contributes to PsychScene Hub with a great article on treatment stratification and personalisation of Neurofeedback using QEEG and neuroCare's leading assessment methods.
Cognitive training, supervised tDCS, neurocoaching and more: Get to know your therapeutic options in times of social distancing.
Weiterlesen … Provide supervised therapies at home
Kyowa and neuroCare sign an equity participation paving the way for a strategic joint venture in Japan
Weiterlesen … neuroCare Group Welcomes Kyowa
How to continue therapies online and remotely during a period of reduced direct contact? Learn more about cognitive training and tDCS for home use.
Weiterlesen … Mental Healthcare in the current crisis - What can we do together?
New study identifies Biomarkers in brain activity which predicts response to certain Depression treatments, a breakthrough in Psychiatry and use of EEG assessment technologies in mental healthcare.
Weiterlesen … Milestone in personalised treatment for Depression
A recent cost-utility analysis has found rTMS is not only more cost-effective than Electroconvulsive Therapy, it produces better health outcomes.
Weiterlesen … rTMS more cost effective than ECT
Nearly 75% of teen patients seeking treatment for insomnia also suffer from an underlying, diagnosed mental health condition, primarily ADHD or depression, according to a new study.
Article by Kay Sukel, originally published by the Dana Foundation
Meet us at Arab Health 2020
Joint booth of Thuringia/Germany, # Z4B26, hall 4
Weiterlesen … Neuromodulation - Innovations at ARAB HEALTH 2020
On 14 - 16 June 2019, Dr. Edith Schneider, Prof. Hartmut Heinrich, Dr. Marion Brickwedde and other speakers gave insights into their work, cases and concepts.
Weiterlesen … Successful Neurofeedback User Convention: Exchange and new impulses for therapy
neuroConn plays leading role in research project to develop a new treatment method for people with ADHD.
Weiterlesen … EEG-guided electrical brain stimulation for ADHD patients